Saturday, 17 August 2019

Biosafe to expand stem cell banking business in India

24 September 2013 | News | By BioSpectrum Bureau

Biosafe's proprietary Sepax cell separation system and Coolmix cryo-preparation cooling and mixing device is gaining popularity in Brazil, Russia, India and China (BRIC)

Biosafe's proprietary Sepax cell separation system and Coolmix cryo-preparation cooling and mixing device is gaining popularity in Brazil, Russia, India and China (BRIC)

Singapore: Biosafe, which is a Switzerland-based manufacturer of automated cell processing systems, partnered with Indian distributor, Span Healthcare, with the objective to expand its stem cell banking business in India.

In the domain of public stem cell banking, Jeevan Blood Bank and Research Center in Chennai is expanding its program and will process its full volume of stem cell samples with Biosafe's proprietary Sepax cell separation system and Coolmix cryo-preparation cooling and mixing device.

In the doamin of family stem cell banking, the renowned companies Cordlife India and Cryobanks International are likewise moving to automated processing exclusively by Sepax.

Mr Olivier Waridel, CEO, Biosafe Group, commented that, "These recent wins illustrate the potential of Biosafe's Sepax technology in Brazil, Russia, India and China (BRIC) economies. Biosafe demonstrates its ability to meet customer expectations through its vast portfolio of processing solutions and is committed to further support stem cell banking expansion in India together with Span Healthcare."

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Will APAC lead the way for innovation in the field of precision medicine?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls